MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 67 filers reported holding MINERVA NEUROSCIENCES INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,007,000 | +33.6% | 130,040 | -2.9% | 0.01% | +20.0% |
| Q2 2019 | $754,000 | -65.0% | 133,931 | -51.1% | 0.01% | -37.5% |
| Q1 2019 | $2,152,000 | +45.1% | 273,840 | +24.4% | 0.01% | -42.9% |
| Q4 2018 | $1,483,000 | -89.4% | 220,063 | -80.2% | 0.01% | -70.8% |
| Q3 2018 | $13,948,000 | +305.2% | 1,111,350 | +166.4% | 0.05% | +152.6% |
| Q2 2018 | $3,442,000 | +10.8% | 417,200 | -16.1% | 0.02% | +18.8% |
| Q1 2018 | $3,107,000 | +8.2% | 497,070 | +4.7% | 0.02% | 0.0% |
| Q4 2017 | $2,872,000 | -25.9% | 474,667 | -2.1% | 0.02% | -36.0% |
| Q3 2017 | $3,878,000 | -25.2% | 484,704 | -15.8% | 0.02% | -34.2% |
| Q2 2017 | $5,182,000 | +49.9% | 575,808 | +33.2% | 0.04% | +40.7% |
| Q1 2017 | $3,457,000 | – | 432,171 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,652,436 | $31,166,000 | 4.20% |
| NEXTHERA CAPITAL LP | 492,958 | $5,792,000 | 3.40% |
| Iguana Healthcare Management, LLC | 150,000 | $1,763,000 | 1.05% |
| Perceptive Advisors | 810,537 | $9,523,000 | 0.68% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,141,333 | $13,411,000 | 0.63% |
| FEDERATED HERMES, INC. | 6,358,642 | $74,714,000 | 0.22% |
| EAM Investors, LLC | 137,685 | $1,618,000 | 0.22% |
| Orbimed Advisors | 556,200 | $6,535,000 | 0.08% |
| J. Goldman & Co LP | 103,281 | $1,214,000 | 0.08% |
| Virtus ETF Advisers LLC | 18,814 | $221,000 | 0.07% |